I

Immuneed

28 employees

Immuneed is developing a new generation of prostate cancer vaccines, based on activation of the body's own immune system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
In-Vitro Immunotoxicity
Complement Activation
Peptides
Safety Assessment
Innate Immunity
Immunotoxicity
Functional studies
Small molecules
Immune profiling
Drug development
Immuno-oncology
Proteins
Contract research organization
Immune complexes
Biologics
Cytokine Release Assay
Platelet activation
non-clinical
Pharmaceutical
Monocyte activation
Virus
Health Care
ADCC & CDC assays
Monoclonal antibodies
MoA

Date founded

2014

Funding rounds raised

Total raised

$507K

from 1 investors over 1 rounds

I

Immuneed raised $507K on September 13, 2016

Investors: Almi Invest

FAQ